Pharmacokinetic and Pharmacodynamic Considerations of Rifamycin Antibiotics for the Treatment of Tuberculosis

Expert Opinion on Drug Metabolism and Toxicology- United Kingdom

doi 10.1080/17425255.2019.1648432

Full Text

Abstract

Available in

Categories

Date

July 30, 2019

Authors

Christine Sekaggya-Wiltshire

Kelly E. Dooley

Publisher

Informa UK Limited

Related search

Pharmacokinetic and Pharmacodynamic Evaluation of Rivaroxaban: Considerations for the Treatment of Venous Thromboembolism

Thrombosis Journal

English

Pharmacokinetic Considerations and Dosing Strategies of Antibiotics in the Critically Ill Patient

Journal of the Intensive Care Society

Critical Care Nursing

Intensive Care Medicine

English

The First Biosimilar Approved for the Treatment of Osteoporosis: Results of a Comparative Pharmacokinetic/Pharmacodynamic Study

Osteoporosis International

English

Pre-Clinical Pharmacokinetic and Pharmacodynamic Data to Support Cefoxitin Nebulization for the Treatment of Mycobacterium Abscessus

Antimicrobial Agents and Chemotherapy

Infectious Diseases

English

New Sampling Techniques for Pharmacokinetic- Pharmacodynamic Modeling

English

Efficacy, Pharmacokinetic and Pharmacodynamic Evaluation of Apaziquone in the Treatment of Non-Muscle Invasive Bladder Cancer

Expert Opinion on Drug Metabolism and Toxicology

English

Reappraisal of Contemporary Pharmacokinetic and Pharmacodynamic Principles for Informing Aminoglycoside Dosing

Pharmacotherapy

English

A Population Pharmacokinetic-Pharmacodynamic Model of Pegfilgrastim

Pharmaceutical Science

English

Mefloquine Pharmacokinetic-Pharmacodynamic Models: Implications for Dosing and Resistance

Antimicrobial Agents and Chemotherapy

Infectious Diseases

English